Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 7 | 2 | 10 | — | — | 19 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 7 | 1 | 3 | — | — | 11 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 2 | 1 | 7 | — | — | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 7 | — | — | — | — | 7 |
Insulin resistance | D007333 | HP_0000855 | — | 1 | — | — | — | — | 1 |
Liver failure | D017093 | HP_0001399 | K72.9 | 1 | — | — | — | — | 1 |
Hepatic insufficiency | D048550 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Insulin peglispro |
INN | insulin peglispro |
Description | Insulin peglispro is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108569 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6Y83I5F10I (ChemIDplus, GSRS) |